CST, TTP LabTech Partner on Cell Analysis Assays

Jan 31, 2008

NEW YORK (GenomeWeb News) – Cell Signaling Technology today said that it will collaborate with TTP LabTech on developing antibody-based assays for high-content cellular analysis.

Danvers, Mass.-based CST intends to use its rabbit monoclonal antibody technology in developing and optimizing a catalog of high-content assays for cellular pathway profiling on TTP LabTech’s Acumen Explorer/eX3 platform. CST said that it will sell the assays to the drug discovery market and also offer them in its profiling services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Main menu